Dr. Shaz is Executive Vice President and Chief Medical and Scientific Officer at New York Blood Center, directing all medical activities, hemophilia services, transfusion services, the cellular therapy laboratory, bone marrow recruitment and donation, perioperative autologous services, and apheresis services.
Additionally, as a Fellow at the Lindsley F. Kimball Research Institute (LFKRI), she is developing a pooled pathogen reduced red blood cell product. She has been widely recognized for her work in massive transfusion and blood donation in underrepresented minorities.
Prior to coming to New York, Dr. Shaz worked at Emory University as an associate professor and director of the transfusion service at Grady Memorial Hospital. Previous to Emory, she was an instructor at Harvard Medical School and assistant medical director of the transfusion service and medical director of the transfusion/apheresis unit at Beth Israel Deaconess Medical Center in Boston.
Dr. Shaz is significantly involved with the trade organization, AABB, serving as a Board Director and previous chair or member of many committees. She is an active member of the College of American Pathologists, helping to advance blood banking and transfusion medicine; and has been a board member, committee chair and active committee member of the American Society for Apheresis. Dr. Shaz is also Associate Editor, TRANSFUSION, and an editorial board member and/or reviewer for several other journals.
She has presented her work extensively throughout the United States, Europe and Africa, and is an author on more than 60 peer-reviewed publications, more than 60 book chapters, and is an editor of several books, including “Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects”. Dr. Shaz has authored many editorials and has contributed to the New York Times on several occasions.